HSBC enters its May 5 quarterly results with a sharply cleaner short book, a month-long rally behind it, and options traders only modestly more cautious than usual — a setup that looks less charged than the stock's recent history might suggest.
The most striking move of the past four weeks has been short covering, not positioning. Estimated short interest fell roughly 21% over April, dropping from around 7.7 million shares in early April to just over 6 million by April 28. That unwind coincided almost exactly with the stock's 12.7% rally to $89.28. The direction of causation is unclear — shorts may have been squeezed out, or they may have covered ahead of the print — but the result is the same: significantly less downside conviction in the lending market heading into earnings.
The borrow market itself tells a loose story. With utilization running near 23%, availability is wide — roughly three shares available for every one already borrowed, well below any stress threshold. Cost to borrow ticked up 34% over the past week, but the absolute level remains negligible at 0.60%. That kind of fee does not reflect a crowded short trade. The short score of 38.2 sits in the 85th percentile of the broader universe on a rank basis, but the underlying components — loose borrow, falling open interest — point to a market that is reducing exposure rather than building it.
Options positioning adds a mild note of caution without screaming defensiveness. The put/call ratio moved to 1.63 on Tuesday, just above its 20-day average of 1.54 — about one standard deviation from normal, not an extreme. Against a 52-week range of 1.07 to 2.64, the current reading lands in the lower third, meaning options traders are notably less defensive than they have been at their most cautious moments this year. The net read is that hedging into May 5 is happening, but not aggressively.
The forward earnings picture provides context for why shorts retreated. HSBC's EPS 12-month forward year-on-year growth estimate ranks in the 97th percentile of the universe, and 90-day EPS momentum sits at the 91st. Those are not the marks of a stock where bears have a compelling fundamental case to press. The two most recent quarterly prints support that: the February 2026 results produced a 7.5% next-day gain, and the October 2025 release saw a 4.9% jump. Both faded over the following week — the five-day return for February was slightly negative, and October settled around +3.9% — but the pattern favours initial upside reactions. On valuation, the trailing P/E has moved to 10.2x, up roughly half a turn over the past 30 days, while price-to-book is running at 1.64x. Neither reads stretched for a diversified global bank generating this kind of earnings trajectory.
On the analyst side, recent direction has been constructive. Keefe, Bruyette & Woods upgraded to Outperform in December 2025, and Bank of America followed with a Buy upgrade the same month, moving off a Neutral rating. No price target data is available for those moves via the US-listed ADR, and longer-dated targets in this dataset reflect stale data that does not reconcile with the current price and should be disregarded. The institutional register is anchored by Ping An, which holds 8.8% of shares unchanged, and BlackRock, which added around 30 million shares in the most recent period — the largest buyer among the top holders.
What to watch on May 5 is whether HSBC's Asia and MENA revenue lines can sustain the earnings momentum that has driven two consecutive strong opening-day reactions — particularly given that China's composite PMI slipped to 50.1 in April from 50.5 prior, a softening in the economic backdrop that the bank has material exposure to.
See the live data behind this article on ORTEX.
Open HSBC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
